RXR agonist S169 inhibits HBV/HDV entry in vitro by disrupting KIF4-dependent NTCP trafficking

  1. Sameh A. Gad
  2. Doaa A. Abo Elwafa
  3. Saied A. Hussein
  4. Kento Fukano
  5. Takanobu Kato
  6. Ikuo Shoji
  7. Kazuaki Chayama
  8. Masamichi Muramatsu
  9. Masanori Isogawa
  10. Takaji Wakita
  11. Daniel Merk
  12. Hussein H. Aly
Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1016/j.antiviral.2025.106214
  2. Version published to 10.1101/2025.04.21.649881 on bioRxiv